We are live on ! Find out more
SLRN

ACELYRIN

Delisted

SLRN was delisted on the 21st of May, 2025.

105 hedge funds and large institutions have $183M invested in ACELYRIN in 2025 Q1 according to their latest regulatory filings, with 22 funds opening new positions, 22 increasing their positions, 41 reducing their positions, and 42 closing their positions.

New
Increased
Maintained
Reduced
Closed

129% more call options, than puts

Call options by funds: $71K | Put options by funds: $31K

100% more funds holding in top 10

Funds holding in top 10: 24 (+2)

14.28% less ownership

Funds ownership: 87.69%73.41% (-14%)

16% less funds holding

Funds holding: 125105 (-20)

34% less capital invested

Capital invested by funds: $276M → $183M (-$93.8M)

46% less repeat investments, than reductions

Existing positions increased: 22 | Existing positions reduced: 41

48% less first-time investments, than exits

New positions opened: 22 | Existing positions closed: 42

Holders
105
Holders Change
-20
Holders Change %
-16%
% of All Funds
1.41%
Holding in Top 10
4
Holding in Top 10 Change
+2
Holding in Top 10 Change %
+100%
% of All Funds
0.05%
New
22
Increased
22
Reduced
41
Closed
42
Calls
$71K
Puts
$31K
Net Calls
+$40K
Net Calls Change
+$22K
Name Holding Trade Value Shares
Change
Change in
Stake
New York State Common Retirement Fund
76
New York State Common Retirement Fund
New York
$38.3K
Bank of Montreal
77
Bank of Montreal
Ontario, Canada
$37.6K +$1.65K +695 +5%
Two Sigma Advisers
78
Two Sigma Advisers
New York
$37.3K -$3.8K -1,600 -10%
PFSRSONJ
79
Police & Firemen's Retirement System of New Jersey
New Jersey
$36.8K
Carson Wealth (CWM LLC)
80
Carson Wealth (CWM LLC)
Nebraska
$32K +$30.8K +12,933 +8,238%
AFP
81
Ausdal Financial Partners
Iowa
$31.6K
SEI Investments
82
SEI Investments
Pennsylvania
$26.6K
Cerity Partners
83
Cerity Partners
New York
$25.7K +$24.8K +10,419 New
QC
84
Quadrature Capital
United Kingdom
$25.3K +$24.4K +10,246 New
HighTower Advisors
85
HighTower Advisors
Illinois
$24.8K -$369 -155 -2%
FIA
86
FNY Investment Advisers
New York
$24K +$23.8K +10,000 New
Group One Trading
87
Group One Trading
Illinois
$18.9K +$12.2K +5,117 +201%
AIP
88
Ameritas Investment Partners
Nebraska
$17.9K
Legal & General Group
89
Legal & General Group
United Kingdom
$16.3K
California State Teachers Retirement System (CalSTRS)
90
California State Teachers Retirement System (CalSTRS)
California
$13.1K
Royal Bank of Canada
91
Royal Bank of Canada
Ontario, Canada
$13K -$41.1K -17,265 -77%
BNP Paribas Financial Markets
92
BNP Paribas Financial Markets
France
$12.5K -$167K -70,053 -93%
Fidelity Investments
93
Fidelity Investments
Massachusetts
$12.3K -$379K -159,335 -97%
TRCT
94
Tower Research Capital (TRC)
New York
$8.98K -$7.75K -3,260 -47%
Mirae Asset Global Investments
95
Mirae Asset Global Investments
South Korea
$8.76K +$64 +27 +0.8%
GFM
96
GF Fund Management
China
$6.34K +$1.1K +462 +22%
AB
97
Amalgamated Bank
New York
$6K
SCM
98
Sterling Capital Management
North Carolina
$3.24K -$2.44K -1,028 -44%
CIAM
99
Caitong International Asset Management
Hong Kong
$3.16K +$3.04K +1,279 New
Daiwa Securities Group
100
Daiwa Securities Group
Japan
$1K

SLRN Hedge Fund Activity: Q1 2025 in Review

105 of the 7,458 institutional investors tracked by Wall St. Rank reported a position in ACELYRIN (SLRN) for Q1 2025, worth a combined $183M — down 34% from $276M a quarter earlier.

Sellers outnumbered buyers: 42 funds closed out of SLRN and 22 opened new positions — a net loss of 20 holders — while 41 trimmed existing stakes and 22 added.

The largest buyer was Tang Capital Management, opening a new position worth an estimated $23.3M. The largest seller was T. Rowe Price Investment Management, cutting an estimated $19.6M.

  • 105 institutional investors held ACELYRIN (SLRN) as of Q1 2025, down from 125 in Q4 2024.
  • Funds reported $183M of ACELYRIN stock for Q1 2025, down 34% quarter-over-quarter.
  • 22 funds opened new ACELYRIN positions in Q1 2025 and 42 closed out, a net change of -20 holders.
  • The largest ACELYRIN buyer in Q1 2025 was Tang Capital Management, an estimated $23.3M added.
  • The largest ACELYRIN seller in Q1 2025 was T. Rowe Price Investment Management, an estimated $19.6M sold.

Based on aggregated 13F filings for Q1 2025.